• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.50% Nasdaq Up 0.18%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    3.80 Down 0.19(4.76%) 10:50AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.99
    Open:3.97
    Bid:3.85 x 2500
    Ask:3.86 x 14100
    1y Target Est:7.58
    Beta:-4.57
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:3.80 - 3.99
    52wk Range:3.26 - 7.97
    Volume:801,025
    Avg Vol (3m):3,765,040
    Market Cap:836.43M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 4.76%836.43M
    GSKUp 0.09%104.31B
    OREXDown 3.08%755.62M
    RHHBYUp 0.57%235.55B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.11
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.83

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback